Prostate News Volume 14.01 | Jan 27 2026

    0
    35






    2026-02-20 | PCN 17.03


    Prostate Cell News by STEMCELL Technologies
    Vol. 17.03 – 20 February, 2026
    TOP STORY

    B4GALNT4-Mediated Glycosylation of PDK1 Activates the PI3K-AKT Signaling Pathway to Promote Prostate Cancer Progression

    Researchers identified beta-1,4-N-acetylgalactosaminyltransferase 4 (B4GALNT4) as a glycogene significantly associated with advanced pathological stages, higher Gleason scores, and poor prognosis in prostate cancer patients.
    [Advanced Science]

    Full Article
    Explore this validated protocol for high-efficiency gene editing of Human Pluripotent Stem Cells using the ArciTectâ„¢ CRISPR-Cas9 System.
    PUBLICATIONSListed by the impact factor of the journal

    YEATS2 Promotes DNA Repair and Induces Anoikis Resistance by Enhancing Chromatin Accessibility to Drive Prostate Cancer Metastasis

    Knockdown of YEATS domain-containing 2 (YEATS2) reduced the metastatic potential of prostate cancer cells both in vivo and in vitro, whereas its overexpression inhibited anoikis and promotes metastasis by upregulating the expression of the DNA damage repair gene RAD50.
    [Oncogene]

    Full Article

    Marine Trichodermamide B Inhibits Prostate Cancer Progression via Catalase Inhibition-Induced Apoptosis

    Investigators explored the anti-cancer effects and mechanisms of action of trichodermamide B in targeting catalase-induced apoptosis in prostate cancer cells.
    [Cell Communication and Signaling]

    Abstract

    Epigenetic Regulation of NDGA and Its Synergistic Inhibition with EZH2 Inhibitors in Prostate Cancer via NRP1

    Using integrating bioinformatics analysis and proteomic research, scientists identified 12 differentially expressed proteins in NDGA-treated prostate cancer cells that were associated with EZH2, a histone methyltransferase and a catalytic component of polycomb repressive complex 2.
    [Acta Pharmacologica Sinica]

    AbstractGraphical Abstract

    The FOSB-IGFBP5-IGF-1 Axis: A Novel Regulatory Pathway That Suppresses Prostate Cancer Growth

    FOSB is downregulated in prostate cancer (PCa), and its high expression in tumors may reduce the risk of PCa progression by influencing characteristic growth-related cancer pathways.
    [Cancer Gene Therapy]

    Abstract

    miR-340 Improves the Efficiency of p53 Gene Therapy in Metastatic Prostate Cancer Cells through Downregulation of MDM2

    Researchers evaluated the impact of miR-340-mediated downregulation of MDM2 on the therapeutic efficacy of p53 gene therapy in p53 non-expressing prostate cancer cells.
    [Scientific Reports]

    Abstract
    Access scientific and product support from STEMCELL Technologies
    REVIEWS

    ADT and Activation of HGF and WNT Axes in Double-Null Prostate Cancer

    Emerging evidence demonstrates that androgen deprivation therapy (ADT) induces HGF and canonical WNT signaling activation, which further elevates nuclear exporting and ribosomal biogenesis to foster tumor lineage plasticity and promote diverse CRPC phenotypes and double-null prostate cancer development.
    [Nature Reviews Urology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer

    Candel Therapeutics, Inc. announced a $100 million royalty funding agreement with funds managed by RTW Investments, subject to FDA approval of aglatimagene in intermediate- to high-risk, localized prostate cancer.
    [Candel Therapeutics, Inc.]

    Press Release

    The Prostate Cancer Foundation Invests $6.3 Million in Next Generation of Prostate Cancer Researchers

    The Prostate Cancer Foundation (PCF) announced $6.3 million in funding for 31 exceptional Young Investigators pursuing groundbreaking discoveries in prostate cancer.
    [PCF]

    Press Release
    FEATURED EVENT

    AACR Annual Meeting 2026

    April 17-22, 2026
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Prostate Cancer Metabolism

    Aarhus University – Aarhus, Denmark

    Postdoctoral Research Fellow – Cancer Metabolism/ Immunometabolism

    Indiana University – Bloomington, Indiana, United States

    Tenure-Track Professor/Associate Professor/Assistant Professor – Biomedical Sciences

    The University of Hong Kong – Hong Kong

    Professor and Chair – Pharmacology

    University of North Carolina at Chapel Hill – Chapel Hill, North Carolina, United States

    Postdoctoral Researcher – Blood and Prostate Cancer

    Albert Einstein College of Medicine – Bronx, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2